Clinical Roundup ALA report: lung cancer survival has improved, but remains significantly lower for people of color November 19, 2021Vol.47 No.43
Clinical Roundup NCI-sponsored trial indicates optimal treatment sequence for BRAF V600 mutant metastatic melanoma November 19, 2021Vol.47 No.43
Clinical Roundup Yale study shows sotigalimab + Opdivo improves outcomes in advanced melanoma November 19, 2021Vol.47 No.43
Clinical Roundup Yale study finds rates of PSA testing for prostate cancer increased after revised national guidelines November 19, 2021Vol.47 No.43
Drugs & Targets FDA approves Keytruda as adjuvant therapy for patients with RCC following nephrectomy November 19, 2021Vol.47 No.43
Drugs & Targets WVU gets FDA approval for clinical trial of drug to treat eye cancer ‘from the inside out’ November 19, 2021Vol.47 No.43
Drugs & Targets Ribonexus, Pierre Fabre sign licensing agreement on small molecules targeting eIF4A November 19, 2021Vol.47 No.43
Capitol Hill ARPA-H, the key element of Biden cancer agenda, faces uncertain future November 12, 2021Vol.47 No.42By Alice Tracey
In Brief Robert Califf nominated by President Biden as FDA commissioner November 12, 2021Vol.47 No.42
